Enhancing mitochondrial biogenesis and function could potentially alleviate some of the neurodegenerative processes associated with tau mutations that contribute to synaptic impairment and cognitive decline in AD and FTD.12, 14, 47, 58. The gene discussed is MAPT; the disease is frontotemporal dementia.